Wai Chun Bio-Technology Limited reported earnings results for the half year ended December 31, 2023. For the half year, the company reported sales was HKD 190.33 million compared to HKD 405.08 million a year ago. Net loss was HKD 6.73 million compared to HKD 7.83 million a year ago.

Basic loss per share from continuing operations was HKD 0.0393 compared to HKD 0.0457 a year ago.